Latest filing published 25 Oct 2021 for Ventyx Biosciences, Inc., €4.3M.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Aaron Royston: trading record in brief
Aaron Royston is a declared insider at 2 companies (board member); the most frequent names are Akero Therapeutics, Inc. and Ventyx Biosciences, Inc. Over a trading history stretching from 24 June 2019 to 25 October 2021, the count stands at 5 filings.
Purchases make up the whole of the open-market record (2 purchases, €7.8M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2021, the count stands at 1 purchase and no sales.
Most recently, on 25 October 2021, the filings show an open-market purchase worth €4.3M in Ventyx Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Aaron Royston
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ▲
Same trade as the filing by venBio Global Strategic Fund III, L.P., counted once
5M USD31SEC312,500 shares@ US$16.00100.0% of flowCommon StockSEC:0000899243-21-041472:1Canonical exit: 23 Jan 2022 (T+90) - 3,684,769 shares0Common StockSEC:0000899243-21-041472:0
- 3,469,759 sharesCommon StockSEC:0001104659-19-037460:1
- 235,099 sharesCommon StockSEC:0001104659-19-037460:2
- ▲
Same trade as the filing by venBio Global Strategic Fund II L.P., counted once
4M USD37SEC250,000 shares@ US$16.00100.0% of flowCommon StockSEC:0001104659-19-037460:0Canonical exit: 22 Sept 2019 (T+90)
5 of 3 declarations
